Cytokines associated with the pathophysiology of aggressive fibromatosis
- 1 July 2000
- journal article
- research article
- Published by Wiley in Journal of Orthopaedic Research
- Vol. 18 (4) , 655-662
- https://doi.org/10.1002/jor.1100180419
Abstract
The rare benign extra-abdominal desmoid tumor is characterized by aggressive invasion of normal tissue. Treatment is complicated by its recurrence, invasiveness, and persistence. The etiology is unknown and the pathophysiology is obscure. Because of exuberant fibroblastic proliferation with collagenous tissue being the primary tissue component, this desmoid tumor has been compared with keloids arising from excessive scar formation in healing wounds. Numerous cytokines are associated with signaling for growth and maintenance of mesenchymal cells. Altered expression of these proteins is associated with many pathologic conditions. It has been proposed that the enhanced expression of platelet-derived growth factor and its receptor characterize desmoid tumors. We tested the hypothesis that the exuberant fibrosis of desmoid tumors may have resulted from the initiation of the cascade of molecular events producing increased expression of cytokines. We used immunohistochemical analysis of cytokines in desmoid tumors compared with keloids and skin to localize the expression of cytokines. The results showed localized increased expression of the cytokines epidermal growth factor transforming growth factor-β, tumor necrosis factor-α, vascular endothelial growth factor, interleukin-1β, and interleukin-6 in the endothelial cells of blood vessels in the tumors. Production of tumor necrosis factor-α and interleukin-1β in tumor tissue was increased, but we did not find increased expression of platelet-derived growth factor. We concluded that the increased expression of cytokines associated with angiogenesis usually found in wound healing and invasive tumors may contribute to the pathophysiology of the desmoid tumor.Keywords
This publication has 19 references indexed in Scilit:
- Polypeptide growth factors: targeted delivery systemsBiomaterials, 1997
- Insulin-like growth factors inhibit interstitial collagenase synthesis in bone cell culturesEndocrinology, 1995
- Platelet‐derived growth factor in fibrous musculoskeletal disorders: A study of pathologic tissue sections and in vitro primary cell culturesJournal of Orthopaedic Research, 1995
- Aggressive FibromatosisJournal of Pediatric Orthopaedics, 1992
- Chemotherapy for Children With Aggressive Fibromatosis and Langerhans?? Cell HistiocytosisClinical Orthopaedics and Related Research, 1991
- PDGF ligand and receptor gene expression during repair of arterial injury.The Journal of cell biology, 1990
- Low-dose chemotherapy of desmoid tumorsCancer, 1989
- Musculoaponeurotic Fibromatosis A Report of 28 Cases and Review of the LiteraturePublished by Wolters Kluwer Health ,1987
- Heparin protects basic and acidic FGF from inactivationJournal of Cellular Physiology, 1986
- Sustained release of epidermal growth factor accelerates wound repair.Proceedings of the National Academy of Sciences, 1985